The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models
Open accessAbstract
Defective brain hormonal signaling has been associated with Alzheimer's disease (AD), a disorder characterized by synapse and memory failure. Irisin is an exercise-induced myokine released on cleavage of the membrane-bound precursor protein fibronectin type III domain-containing protein 5 (FNDC5), also expressed in the hippocampus. Here we show that FNDC5/irisin levels are reduced in AD hippocampi and cerebrospinal fluid, and in experimental AD models. Knockdown of brain FNDC5/irisin impairs long-term potentiation and novel object recognition memory in mice. Conversely, boosting brain levels of FNDC5/irisin rescues synaptic plasticity and memory in AD mouse models. Peripheral overexpression of FNDC5/irisin rescues memory impairment, whereas blockade of either peripheral or brain FNDC5/irisin attenuates the neuroprotective actions of physical exercise on synaptic plasticity and memory in AD mice. By showing that FNDC5/irisin is an important mediator of the beneficial effects of exercise in AD models, our findings place FNDC5/irisin as a novel agent capable of opposing synapse failure and memory impairment in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, cathepsin B and fibronectin type III domain containing protein 5 (FNDC5)/irisin have been shown to enter the brain and enhance neurogenesis and cognition.287”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [287]
In the citing paper
“Irisin administration in a mouse model of Alzheimer disease improves synaptic plasticity and memory function155,156.”
From Exerkines in health, resilience and disease (2022) · cites this paper as [155]
In the citing paper
“We used several commercial ELISA/EIAs employed in the field to quantify plasma irisin field 12, but they measured the same “irisin” concentration in the plasma of F5KO and WT mice, indicating sensitivity or specificity issues (Extended Data Fig. 1d, e).”
From Exercise hormone irisin is a critical regulator of cognitive function (2021) · cites this paper as [12]
In the citing paper
“Moreover, irisin of central (hippocampal) and peripheral origin has been recently shown to promote an increase in cognitive function 119, further highlighting the potential benefits of exercise on healthspan.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Abràmoff, M. D., Magalhães, P. J., & Ram, S. J. (2004) · Utrecht University Repository (Utrecht University) · Cited by 11,816
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871
SUnSET, a nonradioactive method to monitor protein synthesis
Schmidt, E. K., Clavarino, G., Ceppi, M., & Pierre, P. (2009) · Nature Methods · doi:10.1038/nmeth.1314 · Cited by 1,706
Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway
Wrann, C. D., White, J. P., Salogiannnis, J., Laznik-Bogoslavski, D., Wu, J., Ma, D., Lin, J. D., Greenberg, M. E., & Spiegelman, B. M. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.008 · Cited by 1,440
Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386
Effects of Aerobic Exercise on Mild Cognitive Impairment: A Controlled Trial
Baker, L. D., Frank, L. L., Foster-Schubert, K., Green, P. S., Wilkinson, C. W., McTiernan, A., Plymate, S. R., Fishel, M. A., Watson, G. S., Cholerton, B. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.307 · Cited by 1,171
Research works printed but not linked: 1
- Ferreira, S. T., Lourenco, M. V., Oliveira, M. M. & De Felice, F. G. Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease. Front. Cell. Neurosci. 9, 191 (2015).
Cited by
Sorted by citations
Items 301–400 of 934
Aerobic Training and Circulating Neurotrophins in Alzheimer’s Disease Patients: A Controlled Trial
Stein, A. M., Coelho, F. G. D. M., Vital-Silva, T. M., Rueda, A. V., Pereira, J. R., Deslandes, A. C., Camarini, R., & Galduróz, R. F. (2022) · Experimental Aging Research · doi:10.1080/0361073x.2022.2048586 · Cited by 24
A Bibliometric Analysis of the Literature on Irisin from 2012–2021
Liu, J., Qi, B., Gan, L., Shen, Y., & Zou, Y. F. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19106153 · Cited by 25
Updates on Molecular Targets and Epigenetic-Based Therapies for PCOS
Смирнов, В. В., Beeraka, N. M., Butko, D. Y., Nikolenko, V. N., Bondarev, S., Achkasov, E. E., Sinelnikov, M. Y., & Vikram, P. R. H. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01013-x · Cited by 25
Metabolic regulation of aging and age-related disease
Hamrick, M. W., & Stranahan, A. M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101175 · Cited by 27
Stephan, J. S., & Sleiman, S. F. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.600365 · Cited by 25
Consorti, A., Marco, I. D., & Sansevero, G. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.710303 · Cited by 27
Insulin blood-brain barrier transport and interactions are greater following exercise in mice
Brown, C., Pemberton, S., Babin, A., Abdulhameed, N., Noonan, C., Brown, M. B., Banks, W. A., & Rhea, E. M. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00866.2021 · Cited by 25
An exercise-induced messenger boosts memory in Alzheimer’s disease
Chen, X., & Gan, L. (2018) · Nature Medicine · doi:10.1038/s41591-018-0311-4 · Cited by 23
Falkenhain, K., Ruiz‐Uribe, N. E., Haft‐Javaherian, M., Ali, M. A., contributors, S. C., Michelucci, P. E., Schaffer, C. B., & Bracko, O. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235691 · Cited by 25
Xia, E., Xu, F., Hu, C., Kumal, J. P. P., Tang, X., Mao, D., Li, Y., Wu, D., Zhang, R., Wu, S., et al. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.08.010 · Cited by 22
Xu, H., Tian, X., Wang, Y., Lin, J., Zhu, B., Chen, Z., Wang, B., Zhang, X., Sun, Y., Li, N., et al. (2024) · Biology · doi:10.3390/biology13100809 · Cited by 30
Gruhn, K., Siteneski, A., Camargo, A., Freitas, A. E., Olescowicz, G., Brocardo, P. S., & Rodrigues, A. L. S. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113040 · Cited by 22
Irisin-Associated Neuroprotective and Rehabilitative Strategies for Stroke
Huberman, M. A., d’Adesky, N., Niazi, Q. B., Pérez‐Pinzón, M. A., Bramlett, H. M., & Raval, A. P. (2021) · NeuroMolecular Medicine · doi:10.1007/s12017-021-08666-y · Cited by 23
Cassilhas, R. C., Sousa, R. A. L. D., Caxa, L., Viana, V. A. R., MEEUSEN, R. R., Gonçalves, F. L. T., Magalhães, C. O. D. E., Tufik, S. B., Dias‐Peixoto, M. F., Monteiro-Júnior, R. S., et al. (2021) · Air Quality Atmosphere & Health · doi:10.1007/s11869-021-01083-x · Cited by 23
Chelette, B. M., Loeven, A. M., Gatlin, D. N., Conde, D. R. L., Huffstetler, C. M., Qi, M., & Fadool, D. A. (2021) · The Journal of Physiology · doi:10.1113/jp282112 · Cited by 22
Zheng, Y., He, J., Yang, D., Yuan, M., Liu, S., Dai, F., Jia, Y., & Cheng, Y. (2022) · Biology of Reproduction · doi:10.1093/biolre/ioac125 · Cited by 22
Therapeutic potential of exercise-hormone irisin in Alzheimer’s disease
Kim, E., Tanzi, R. E., & Choi, S. H. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00098 · Cited by 24
Inoue, D. S., & Gomes, M. J. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100838 · Cited by 23
Leem, Y., Park, J., Chang, H., Park, J., & Kim, H.-S. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1560-z · Cited by 21
Farshbaf, M. J., Garasia, S., Moussoki, D. P. K., Mondal, A. K., Cherkowsky, D., Manal, N., & Alviña, K. (2020) · Behavioral Neuroscience · doi:10.1037/bne0000367 · Cited by 23
Faienza, M. F., Brunetti, G., Grugni, G., Fintini, D., Convertino, A., Pignataro, P., Crinò, A., Colucci, S. C., & Grano, M. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01533-4 · Cited by 23
Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer’s disease
Dhiman, A., Handa, M., Ruwali, M., Singh, D. P., Kesharwani, P., & Shukla, R. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.03.006 · Cited by 21
Muscle-brain communication in pain: The key role of myokines
Wang, Y., Wu, Z., Wang, D., Huang, C., Xu, J., Liu, C., & Yang, C. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.11.017 · Cited by 21
Alanko, V., Udeh‐Momoh, C. T., Kivipelto, M., & Matton, A. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.9 · Cited by 22
Irisin improves BBB dysfunction in SAP rats by inhibiting MMP-9 via the ERK/NF-κB signaling pathway
Guo, P., Liu, L., Yang, X., Li, M., Zhao, Q., & Wu, H. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110300 · Cited by 21
Dicarlo, M., Pignataro, P., Zerlotin, R., Suriano, C., Zecca, C., Dell’Abate, M. T., Storlino, G., Oranger, A., Sanesi, L., Mori, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119111 · Cited by 21
Update on modifiable risk factors for Alzheimer's disease and related dementias
Jaisa-aad, M., Muñoz‐Castro, C., & Serrano‐Pozo, A. (2024) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001243 · Cited by 21
Waseem, R., Shamsi, A., Mohammad, T., Alhumaydhi, F. A., Kazim, S. N., Hassan, M. I., Ahmad, F., & Islam, A. (2021) · ACS Omega · doi:10.1021/acsomega.1c00517 · Cited by 22
Loss of association between plasma irisin levels and cognition in Alzheimer’s disease
Kim, K. Y., Kwak, S., Ha, J., Oh, D. J., Kim, M., Cho, S. Y., Kim, H., Lee, J., & Kim, E. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105624 · Cited by 24
Role and Functions of Irisin: A Perspective on Recent Developments and Neurodegenerative Diseases
Minuti, A., Raffaele, I., Scuruchi, M., Lui, M., Muscarà, C., & Calabrò, M. (2025) · Antioxidants · doi:10.3390/antiox14050554 · Cited by 27
Irisin promotes autophagy and attenuates NLRP3 inflammasome activation in Parkinson’s disease
Zhu, M., Peng, Q., Li, S., Zhang, G., & Zhang, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114201 · Cited by 21
Effects of physical exercise on memory in type 2 diabetes: a brief review
Sousa, R. A. L. D., Caria, A. C. I., & Cassilhas, R. C. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00752-1 · Cited by 19
Waseem, R., Shamsi, A., Khan, T., Hassan, M. I., Kazim, S. N., Shahid, M., & Islam, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115965 · Cited by 20
Li, G., Qin, H., Zhou, M., Zhang, T., Zhang, Y., Ding, H., Xu, L., & Song, J. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.02.023 · Cited by 20
Zhang, Y., Wang, L., Kang, H., Lin, C.-Y. J., & Fan, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076551 · Cited by 21
Yang, Q., Yan, C., Sun, Y., Xie, Z., Yang, L., Jiang, M., Ni, J., Chen, B., Xu, S., Yuan, Z., et al. (2024) · Advanced Science · doi:10.1002/advs.202400480 · Cited by 22
Non-conventional compounds with potential therapeutic effects against Alzheimer’s disease
de Castro, A. A., Soares, F. V., Pereira, A. F., Polisel, D. A., Caetano, M. S., Leal, D. H. S., da Cunha, E. F. F., Nepovimová, E., Kuča, K., & Ramalho, T. C. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1608823 · Cited by 20
Nature’s Derivative(s) as Alternative Anti-Alzheimer’s Disease Treatments
Sharma, A., & Kumar, Y. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-190137 · Cited by 21
BMAL1/PGC1α4-FNDC5/irisin axis impacts distinct outcomes of time-of-day resistance exercise
Guo, M., Shen, F., Guo, X., Zhang, J., Ma, Y., Wu, X., Zuo, H., Yao, J., Hu, Y., Wang, D., et al. (2024) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2024.100968 · Cited by 21
Li, N., Wang, B., Wang, Y., Tian, X., Lin, J., Sun, X., Sun, Y., Zhang, X., Xu, H., Li, M., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04801-z · Cited by 21
Lin, J., Shao, X., Shi, T., Wang, H., Zhang, P., Zhou, Y., Liu, N., He, Y., Fang, D., Shi, Y., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01075-5 · Cited by 20
Pharmacological and physiological roles of adipokines and myokines in metabolic-related dementia
Arjunan, A., & Song, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114847 · Cited by 20
Liu, X., Hu, Q., Xu, T., Yuan, Q., Hu, Q., Hu, N., Sun, W., Bai, Y., Liu, L., Feng, J., et al. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148537 · Cited by 19
Du, Z.-Y., Zhu, H.-L., Chang, W., Zhang, Y., Ling, Q., Wang, K., Zhang, J., Zhang, Q.-B., Kan, X.-L., Wang, Q., et al. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.133997 · Cited by 19
Interactions between Beta-Amyloid and Pericytes in Alzheimer’s Disease
Li, Y.-Y., Guo, D.-D., Duan, R., & Li, Y. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2904136 · Cited by 19
Ribeiro, F. C., Cozachenco, D., Argyrousi, E. K., Staniszewski, A., Wiebe, S. A., Calixtro, J. D., Soares‐Neto, R. L., Al‐Chami, A., Sayegh, F. E., Bermudez, S., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14034 · Cited by 19
Self-citationLi, Q., Xu, F., Zhang, Q., Li, X., Guo, M., Zhang, Y., Wang, Z., Wang, J., Zhao, J., Tian, Y., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116898 · Cited by 19
A brief overview about the physiology of fibronectin type III domain-containing 5
Zhang, X., Hu, C., Yuan, Y., Ma, Z., & Tang, Q. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109805 · Cited by 18
The Systemic Effects of Exercise on the Systemic Effects of Alzheimer’s Disease
Aczél, D., György, B., Bakonyi, P., BukhAri, R., Pinho, R. A., Boldogh, I. R., Gu, Y., & Radak, Z. O. (2022) · Antioxidants · doi:10.3390/antiox11051028 · Cited by 19
Increasing the health span: unique role for exercise
Gaesser, G. A., Hall, S. E., Angadi, S. S., Poole, D. C., & Racette, S. B. (2025) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00049.2025 · Cited by 22
Lin, H., Yin, L., Liu, W., Li, R., Jiang, T., Yang, M., Cao, Y., Wang, S., Yu, Y., Chen, C., et al. (2025) · Advanced Science · doi:10.1002/advs.202410209 · Cited by 23
Kang, J., Liu, M., Yang, Q., Dang, X., Li, Q., Wang, T., Qiu, B., Zhang, Y., Guo, X., Li, X., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1558078 · Cited by 21
The 2019 yearbook of Neurorestoratology
Huang, H., Chen, L., Mao, G., Bach, J., Xue, Q., Han, F., Guo, X., Otom, A. H., Chernykh, E. R., Alvarez, E. O., et al. (2020) · Journal of Neurorestoratology · doi:10.26599/jnr.2020.9040004 · Cited by 19
Feng, X.-W., Hadizadeh, M., Zheng, L.-H., & Li, W.-H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195903 · Cited by 21
Liu, C., Wong, P. Y., Chow, S. K., Cheung, W., & Wong, R. M. Y. (2022) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2022.10.001 · Cited by 18
Long-term exercise training inhibits inflammation by suppressing hippocampal NLRP3 in APP/PS1 mice
Li, X., Jin, Y., Ding, X., Zhu, T., Wei, C., & Li, Y. (2023) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2023.09.009 · Cited by 19
Cheon, J., Kwon, S.-Y., & Kim, M. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14432 · Cited by 20
Ji, W., Liu, K., Zhao, G., Wu, F., Jiang, Y. Y., Hou, L., Zhang, M., & Mao, L. (2020) · ACS Sensors · doi:10.1021/acssensors.0c02326 · Cited by 18
Research trends and hotspots of exercise for Alzheimer’s disease: A bibliometric analysis
Chen, B., Fu, Y., Song, G., Zhong, W., & Guo, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.984705 · Cited by 18
Barros, L., Eichwald, T., Solano, A. F., Scheffer, D. D. L., da Silva, R. A., Gaspar, J. M., & Latini, A. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.03.009 · Cited by 18
Exercise and cardiovascular health: new routes to reap more rewards
Channon, K. M. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz264 · Cited by 18
Leardini-Tristao, M., Charles, A.-L., Lejay, A., Pizzimenti, M., Meyer, A., Estato, V., Tibiriçá, E., Andres, E., & Geny, B. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050653 · Cited by 17
“Physical exercise protected AβOs mice from cognitive dysfunction and increased the hippocampal levels of FNDC5/irisin, as compared to sedentary mice [52].”
BackgroundWang, S., Zhou, Y., Wu, Y., Lang, Y., Mao, Y., Pan, G., & Gao, Z. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1505650 · Cited by 17
Extracellular vesicles contribute to the beneficial effects of exercise training in APP/PS1 mice
Fuller, O. K., McLennan, E. D., Egan, C. L., Perera, N., Terry, L. V., Pyun, J., de Mendonca, M., Telles, G. D., Smeuninx, B., Burrows, E. L., et al. (2025) · iScience · doi:10.1016/j.isci.2025.111752 · Cited by 17
Irisin is an Effector Molecule in Exercise Rehabilitation Following Myocardial Infarction (Review)
Qin, S., Tian, Z., Boidin, M., Buckley, B. J. R., Thijssen, D. H. J., & Lip, G. Y. H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.935772 · Cited by 17
Aerobic exercise inhibits renal EMT by promoting irisin expression in SHR
Luo, M., Luo, S., Xue, Y., Chang, Q., Yang, H., Dong, W., Zhang, T., & Cao, S. (2023) · iScience · doi:10.1016/j.isci.2023.105990 · Cited by 17
de Almeida, M. F., Farizatto, K. L. G., Almeida, R. S., & Bahr, B. A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102162 · Cited by 17
Dong, Q., Han, Z., Gao, M., & Tian, L. (2024) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-024-04701-3 · Cited by 17
New insights into the roles of Irisin in diabetic cardiomyopathy and vascular diseases
Zhang, T., Qian, Y., Huang, W., Feng, J., & Liu, H. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116631 · Cited by 22
Morgado, J., Diniz, L. P., Araújo, A. P. B., Antônio, L. M. D. S., Mota-Araujo, H. P., Pinheiro, P. D. S. M., Sagrillo, F. S., Vargas, G., Ferreira, S. T., Figueiredo, C. P., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16439 · Cited by 18
Self-citationZhao, R. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00428-7 · Cited by 17
Falco, A. D., Kincheski, G. C., Atrián‐Blasco, E., Hureau, C., Ferreira, S. T., & Rey, N. A. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000578 · Cited by 17
Self-citationKarlsson, L., Alvarado, M. N. G., Motalleb, R., Wang, Y., Wang, Y., Börjesson, M., Zhu, C., & Kuhn, H. G. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02189-6 · Cited by 17
The production, detection, and origin of irisin and its effect on bone cells
Zhong, X., Sun, X., Shan, M., Zhao, X., Zhang, R., Zhao, Y., & Yang, Q. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.181 · Cited by 17
Liu, Y., Ding, X., Jia, S., & Gu, X. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00802 · Cited by 16
Non-pharmacological treatment of Alzheimer’s disease: an update
Wang, S., Xu, H., Liu, G., & Chen, L.-M. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1527242 · Cited by 19
Kim, M.-H., & Leem, Y. (2019) · Physical Activity and Nutrition · doi:10.20463/jenb.2019.0029 · Cited by 17
The role of Irisin in multiorgan protection
Ma, J., & Chen, K. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06067-1 · Cited by 17
Yang, F., Wang, Z., Li, B., He, Y., Du, F., Tian, S., Zhang, Y., & Yang, Y. (2021) · International Journal of Stem Cells · doi:10.15283/ijsc21005 · Cited by 16
Different Exercise Time on 5-HT and Anxiety-like Behavior in the Rat With Vascular Dementia
Fan, Y., Zhang, L., Kong, X., Liu, K., & Wu, H. (2022) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175221082743 · Cited by 16
Waseem, R., Shamsi, A., Khan, T., Anwer, A., Shahid, M., Kazim, S. N., Hassan, M. I., & Islam, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30353 · Cited by 16
Ren, J., & Xiao, H. (2023) · Life · doi:10.3390/life13122285 · Cited by 17
Cerebral Benefits Induced by Electrical Muscle Stimulation: Evidence from a Human and Rat Study
Chaney, R., Leger, C., Wirtz, J., Fontanier, E., Méloux, A., Quirié, A., Martin, A., Prigent‐Tessier, A., & Garnier, P. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031883 · Cited by 19
Park, S. H., Ko, J. R., & Han, J. (2024) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2024.28.2.145 · Cited by 16
The role of exercise-related FNDC5/irisin in depression
Liu, Y., Fu, X., Zhao, X., Cui, R., & Yang, W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1461995 · Cited by 25
Li, S., Li, M., Li, G., Li, L., Yang, X., Zuo, Z., Zhang, L., Hu, X., & He, X. (2025) · Aging Cell · doi:10.1111/acel.14496 · Cited by 17
Ratne, N., Jari, S., Tadas, M., Katariya, R., Kale, M. B., Kotagale, N. R., Madia, D., Umekar, M. J., & Taksande, B. G. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102687 · Cited by 17
Peng, L., Li, S., Huang, Q., Sun, Y., Sun, J., Luo, T., Wang, Y., Hu, Z., Lai, W., & Peng, H. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70235 · Cited by 16
Clark, I. A., & Vissel, B. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1618710 · Cited by 16
Colovati, M. E. S., Novais, I. D. P., Zampol, M., Mendes, G. D., Cernach, M. C. S. P., & Zanesco, A. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x202010098 · Cited by 16
Cariati, I., Bonanni, R., Pallone, G., Scimeca, M., Frank, C., Tancredi, V., & D’Arcangelo, G. (2021) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk6040101 · Cited by 18
Sarcopenia is a predictor for Alzheimer’s continuum and related clinical outcomes
Kim, J., Suh, S., Park, Y. J., Kang, M., Chung, S. J., Lee, E. S., Jung, H., Eo, J. S., Koh, S., Oh, K., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-62918-y · Cited by 15
The Effect of Melatonin and Exercise on Social Isolation-Related Behavioral Changes in Aged Rats
Alghamdi, B. S. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.828965 · Cited by 15
Abdulghani, A., Poghosyan, M., Mehren, A., Philipsen, A., & Anderzhanova, E. A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.997054 · Cited by 17
Khoury, R. E., Saad, J., Jabre, V., Ghayad, L. M., Khalifeh, M., Houbeika, R. Y., Ahmad, P. E., Mezher, A., Masri, D. E., Haddad, Z. L., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14705 · Cited by 16
APP in the Neuromuscular Junction for the Development of Sarcopenia and Alzheimer’s Disease
Wu, M., Zou, W.-J., Lee, D., Mei, L., & Xiong, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097809 · Cited by 17
Bellettini‐Santos, T., Batista-Silva, H., Pereira, C. M., Castro, F. C. D. A. Q., Barcelos, R. M., Chiepe, K. C. M. B., Rossoni, J. V., Ambrósio, R. P., da Silva, B. S., Chiarelli-Neto, O., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512440 · Cited by 16
Recapitulation of anti-aging phenotypes by global overexpression of PTEN in mice
Hager, M., Chang, P. S., Lee, M., Burns, C. M., Endicott, S. J., Miller, R. A., & Li, X. (2023) · GeroScience · doi:10.1007/s11357-023-01025-8 · Cited by 16
Inhibition of Alzheimer's disease by 4-octyl itaconate revealed by RNA-seq transcriptome analysis
Liu, Y., Xia, P., Zong, S., Zheng, N., Cui, X., Wang, C., Wang, M., Wang, X., Yu, S., Zhao, H., et al. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176432 · Cited by 15
The cerebroprotection and prospects of FNDC5/irisin in stroke
Liu, Y., Liu, Y., Zhang, X., Yan, G., Qi, L., Yong, V. W., & Xue, M. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109986 · Cited by 17
Metadata
- Authors
- Lourenco, M. V., Frozza, R. L., de Freitas, G. B., Zhang, H., Kincheski, G. C., Ribeiro, F. C., Gonçalves, R. A., Clarke, J. R., Beckman, D., Staniszewski, A., Berman, H., Guerra, L. A., Forny-Germano, L., Meier, S., Wilcock, D. M., de Souza, J. M., Alves-Leon, S., Prado, V. F., Prado, M. A. M., Abisambra, J. F., Tovar-Moll, F., Mattos, P., Arancio, O., Ferreira, S. T., & De Felice, F. G.
- Affiliations
- Universidade Federal do Rio de Janeiro (BR)
- Columbia University (US)
- Queen's University (CA)
- University of Kentucky (US)
- Western University (CA)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Arancio, Ottavio
- Ferreira, Sergio T.
- ORCID
- Lourenco, Mychael V.
- Frozza, Rudimar L.
- Zhang, Hong
- Kincheski, Grasielle C.
- Ribeiro, Felipe C.
- Gonçalves, Rafaella A.
- Clarke, Julia R.
- Beckman, Danielle
- Staniszewski, Agnieszka
- Berman, Hanna
- Meier, Shelby
- Wilcock, Donna M.
- Prado, Marco A. M.
- Abisambra, Jose F.
- Tovar-Moll, Fernanda
- Mattos, Paulo
- Arancio, Ottavio
- Ferreira, Sergio T.
- Venue
- Nature Medicine
- Published
- 2019-01
- Volume
- 25
- Issue
- 1
- Pages
- 165-175
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC6327967
- OpenAlex
- W2905067650
- Cited by
- 935
- References
- 71
- Citations by year
- 2026: 109 · 2025: 137 · 2024: 132 · 2023: 153 · 2022: 138 · 2021: 109 · 2020: 96 · 2019: 59
- FWCI
- 45.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Arca - Repositório Institucional da Fiocruz (submittedVersion, other-oa)
- Scholarship@Western (Western University) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Funders
- Northwestern University
- Harvard University
- Weston Brain Institute
- Alzheimer Society
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Queen's University
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (Code 001, 406436/2016-9, 465346/2014, 465346/2014–6, 2013‐0, 473324/2013-0)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (201.432/2014, 202.817/2016, 202.944/2015)
- International Society for Neurochemistry (CAEN 1B)
- National Institutes of Health (AG028 383, T32 grant)
- Institute for Translational Neuroscience (465346)
- Canadian Institutes of Health Research (89919, MOP89919)
- National Institute on Aging (AG-028383, P30AG028383, AG057461, T32AG057461)
- National Institute of Neurological Disorders and Stroke (R01NS049442, R01NS091329)
- National Institute on Minority Health and Health Disparities (L32 MD009205)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- FNDC5, irisin, Alzheimer's disease, physical activity, myokines, synaptic plasticity, long-term potentiation, memory impairment, hippocampus, cerebrospinal fluid, neuroprotection, learning and memory impairment
- MeSH terms
- Adolescent, Adult, Aged, Alzheimer Disease, Animals, Brain, Disease Models, Animal, Female, Fibronectins, Humans, Male, Memory Disorders, Mice, Inbred C57BL, Middle Aged, Neuronal Plasticity, Physical Conditioning, Animal, Recombinant Proteins, RNA, Messenger, Signal Transduction, Down-Regulation, Long-Term Potentiation, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review